EUVIMED · CrossrefJournal
Molecular Therapy - Oncolytics
ISSN 2372-7705 · Elsevier BV
Latest articles
miR-146a inhibits ovarian tumor growth in vivo via targeting immunosuppressive neutrophils and enhancing CD8+ T cell infiltration
Peritoneal-directed chimeric oncolytic virus CF17 prevents malignant ascites and improves survival in gastric cancer peritoneal metastases
Targeting the lactic acid metabolic pathway for antitumor therapy
Improved oncolytic activity of a reovirus mutant that displays enhanced virus spread due to reduced cell attachment
Beyond ENO1, emerging roles and targeting strategies of other enolases in cancers
Tagmentation-based analysis reveals the clonal behavior of CAR-T cells in association with lentivector integration sites
Neoadjuvant use of oncolytic herpes virus G47Δ prevents local recurrence after insufficient resection in tongue cancer models
Hypoxia-regulated secretion of IL-12 enhances antitumor activity and safety of CD19 CAR-T cells in the treatment of DLBCL
A new strategy for treating colorectal cancer: Regulating the influence of intestinal flora and oncolytic virus on interferon
Efficacy of coxsackievirus A21 against drug-resistant neoplastic B cells
PTEN potentiation of oncolytic HSV therapy for glioblastoma
Enhancing the effectiveness of γδ T cells by mRNA transfection of chimeric antigen receptors or bispecific T cell engagers
Oncolytic adenovirus coding for bispecific T cell engager against human MUC-1 potentiates T cell response against solid tumors
Enhanced genomic stability of new miRNA-regulated oncolytic coxsackievirus B3
Gene-edited and CAR-NK cells: Opportunities and challenges with engineering of NK cells for immunotherapy
Dual EGFR- and TfR-targeted gene transfer for sodium iodide symporter gene therapy of glioblastoma
Development and comparison of 68Ga/18F/64Cu-labeled nanobody tracers probing Claudin18.2
Novel roles of METTL1/WDR4 in tumor via m7G methylation
DAP10 integration in CAR-T cells enhances the killing of heterogeneous tumors by harnessing endogenous NKG2D
Efficacy of cancer-specific anti-podoplanin CAR-T cells and oncolytic herpes virus G47Δ combination therapy against glioblastoma
Noncoding RNA-mediated macrophage and cancer cell crosstalk in hepatocellular carcinoma
CAR T cell therapy and the tumor microenvironment: Current challenges and opportunities
Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor immunity
Inhibition of MEK-ERK pathway enhances oncolytic vaccinia virus replication in doxorubicin-resistant ovarian cancer
Physiological lentiviral vectors for the generation of improved CAR-T cells
Targeting primary and metastatic tumor growth in an aggressive breast cancer by engineered tryptophan auxotrophic Salmonella Typhimurium
Oncolytic measles vaccines encoding PD-1 and PD-L1 checkpoint blocking antibodies to increase tumor-specific T cell memory
The role of long non-coding RNAs in the pathogenesis of head and neck squamous cell carcinoma
SNX5 suppresses clear cell renal cell carcinoma progression by inducing CD44 internalization and epithelial-to-mesenchymal transition
ENO1 and Cancer
EUVIMED